Skip to main content

Home/ MaRS/ Group items tagged Veronika Litinski

Rss Feed Group items tagged

Assunta Krehl

Ontario - A Leading Centre Of Stem Cell Research That Is Building A Foundation - Biosci... - 0 views

  •  
    Ontario is the home of stem cell research. Canada is ranks as one of the top 6 countries worldwide for its ongoing leadership in stem cell research. According to the Regenerative Medicine reported release in January 2008 by Veronika Litinski and Lincoln Kim, Ontario consistently ranks in the top 5 regions in North America for Stem Cell Research.
  •  
    Ontario is the home of stem cell research. Canada is ranks as one of the top 6 countries worldwide for its ongoing leadership in stem cell research. According to the Regenerative Medicine reported release in January 2008 by Veronika Litinski and Lincoln Kim, Ontario consistently ranks in the top 5 regions in North America for Stem Cell Research. Jul 11, 2008
Assunta Krehl

Pursuit Of Employment: Toronto Innovation Forum June 16, 2009 Program "Opportunity, Cre... - 0 views

  • • Best Practices in Venture Creation (Room 1)Veronika Litinski, Practice Lead, Healthcare and Life Sciences, MaRSAn overview of what makes your business valuable to investors and how to develop a viable business strategy.
  •  
    Outlines Event schedule for Toronto Innovation Forum June 16, 2009 Program "Opportunity, Creativity and Partnership"
  •  
    Outlines Event schedule for Toronto Innovation Forum June 16, 2009 Program "Opportunity, Creativity and Partnership." Veronika Litinski, Practice Lead, Healthcare and Life Sciences, MaRS will talk about Best Practices in Venture Creation.
Assunta Krehl

Quest for a wonder drug started with shrew bait - The Globe and Mail - August 8, 2012 - 0 views

  •  
    "Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.
Assunta Krehl

Automate to Market - The Scientist - January 2010 - 1 views

  •  
    The Scientist spoke with researchers who are automating and commercializing the latest technologies to aid life science work. Ameer Taha, founder, Certo Labs, Toronto and Veronika Litinski, health-care and life sciences practice lead at the MaRS Centre, a Toronto-based innovation cluster that engages researchers in commercializing their inventions were interviewed. Litinski states that "Before people start spending money on [developing] a product, we want them to think about the value chain and how the industry ecosystem is organized."
Assunta Krehl

Commercialization Gap - BioBEAT - 0 views

  • Groups like MaRS and OCE exist to offer funding and managerial guidance to help entrepreneurs take their great con- cept to market. Our role at MaRS is to help innovators bridge this commercialization gap. We provide advisory services, market intelligence and seed funding in conjunc-
  • tion with OCE
  • Veronika Litinski is the Director of MaRS Venture Group. For assistance in drafting this article, thanks to Kevin Downing, Asso- ciate with MaRS Venture Group
  •  
    The Commercialization Gap is the transition from basic knowledge and a commercialization product. The issue the commercialization gap is explored.
  •  
    The Commercialization Gap is the transition from basic knowledge and a commercialization product. The issue the commercialization gap is explored. Feb 1, 2007
1 - 5 of 5
Showing 20 items per page